Aerovate discloses stockholder lawsuits and demand letters over merger with Jade Biosciences

Jade Biosciences, Inc.

Two lawsuits filed March 27, 2025 in NY state court alleging misrepresentations in S-4; seek injunctive relief or damages.
Ten demand letters received Dec 14, 2024 – Apr 9, 2025 requesting additional disclosures in the S-4.
Aerovate voluntarily supplements S-4 with background details on reverse merger process, Wedbush/Lucid engagements, and updated financial tables.
Company denies legal necessity of additional disclosures but adds them to avoid nuisance and delay.
Merger agreement with Jade (reverse merger) remains subject to stockholder vote and closing conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.